Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
The new treatment is designed to be less invasive than the current interferon therapy. Instead of a 24 to 48 week course of injections, the new treatment is being administered as oral polymerase and protease inhibitors taken over a 12 week period.
The new treatment has thus far shown a 95 percent cure rate, 15 percent better than the interferon therapy cure rate.
More Articles on Gastroenterology:
LA Peer Health System Hosts Review of Barrett’s Esophagus Articles
Huntington Hospital Appoints Dr. David Rivadeneira Surgical Services Director
Dr. Harold Kaplan Teaches at Quinnipac University Medical School
